This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a methanesulfonyl group and a piperidine ring, makes it valuable for designing compounds with potential therapeutic effects, particularly in the areas of central nervous system disorders and oncology. It is often employed in the creation of small molecule inhibitors or modulators targeting specific enzymes or receptors. Additionally, its functional groups allow for further chemical modifications, enabling the development of novel drug candidates with optimized pharmacokinetic and pharmacodynamic properties.